Differential desensitization of μ- and δ- opioid receptors in selected neural pathways following chronic morphine treatment

British Journal of Pharmacology

Volumn 117, Issue 1, 1996, Pages 161-169

  Noble, Florence ^a,b   Cox, Brian M ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b Laboratoire de Pharmacochimie   (France)

Author keywords

Adenylyl cyclase; Caudate putamen; Chronic treatment; Desensitization; Morphine; Nucleus accumbens; Opioid receptors; Periaqueductal gray; Thalamus

Indexed keywords

2 AMINO 4 PHOSPHONOBUTYRIC ACID; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; ADENYLATE CYCLASE; DELTA OPIATE RECEPTOR; DELTORPHIN II [2 DEXTRO ALANINE]; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; GLUTAMIC ACID; METABOTROPIC RECEPTOR; MORPHINE; MU OPIATE RECEPTOR; NALOXONE; NEUROTRANSMITTER; OPIATE; OPIATE AGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG DEPENDENCE; ENZYME ACTIVITY; ENZYME REGULATION; LONG TERM CARE; MALE; NERVE TRACT; NONHUMAN; NUCLEUS ACCUMBENS; OSMOTIC PUMP; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; PUTAMEN; RAT; RECEPTOR DOWN REGULATION; SIDE EFFECT; SUBCUTANEOUS DRUG ADMINISTRATION; THALAMUS; WITHDRAWAL SYNDROME;

EID: 0029671014     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15169.x     Document Type: Article

References (54)

1. ACQUAS, E. & DI CHIARA, G. (1992). Depression of mesolimbic dopamine transmission and sensitization to morphine during opiate abstinence. J. Neurochem., 58, 1620-1625.
2. ADAMS, J.U. & HOLTZMAN, S.G. (1990). Tolerance and dependence after continuous morphine infusion from osmotic pumps measured by operant responding in rats. Psychopharmacology, 100, 451-458.
3. AGHAJANIAN, C. K. (1978). Tolerance of locus coeruleus neurons to morphine and suppression of withdrawal response by clonidine. Nature, 276, 186-188.
4. ATTALI, B., SAYA, D. & VOGEL, Z. (1989). N-opiate agonists inhibit adenylate cyclase and produce heterologous desensitization in rat spinal cord. J. Neurochem., 52, 360-369.
5. BANDLER, R. & SHIPLEY, M.T. (1994). Columnar organization in the midbrain periaqueductal gray: modules for emotional expression. Trends Neurosci., 17, 379-389.
6. BASBAUM, A.I. & FIELDS, H.L. (1984). Endogenous opioid pain control systems: Brainstem spinal pathways and endorphin circuitry. Annu. Rev. Neurosci., 7, 309-338.
7. BEITNER-JOHNSON, D., GUTTART, X. & NESTLER, E.J. (1992). Neurofilament proteins and the mesolimbic dopamine system: common regulation by chronic morphine and chronic cocaine in the rat ventral tegmental area. J. Neurosci., 12, 2165-2176.
8. BEITNER-JOHNSON, D. & NESTLER, E.J. (1991). Morphine and cocaine exert common chronic actions on tyrosine hydroxylase in dopaminergic brain reward regions. J. Neurochem., 57, 344-347.
9. BOESS, F.G. & MARTIN, L.L. (1994). Review: molecular biology of 5-HT receptors. Neuropharmacology, 33, 275-317.
10. BOZARTH, M.A. (1986). Neural basis of psychomotor stimulant and opiate reward: evidence suggesting the involvement of a common dopaminergic system. Behav. Brain Res., 22, 107-116.
11. BOZARTH, M.A. (1994). Physical dependence produced by central morphine infusions: an anatomical mapping study. Neurosci. Behav. Rev., 18, 373-387.
12. BROWN, B.L., ALBANO, J.D.M., EKINS, R.P., SGHERZI, A.M. & TAMPION, W. (1971). A simple and sensitve saturation assay method for measurement of adenosine 3′,5′-cyclic monophosphate. Biochem. J., 121, 561-562.
13. CADOR, M., TAYLOR, J.R. & ROBBINS, T.W. (1991). Potentialion of the effects of reward-related stimuli by dopaminergic-dependent mechanisms in the nucleus accumbens. Psychopharmacology, 104, 377-385.
14. CRAIN, S.M., CRAIN, B. & PETERSON, E.R. (1982). Development of cross-tolerance to 5-hydroxytryptamine in organotypic cultures of mouse spinal cord-ganglia during chronic exposure to morphine. Life Sci., 31, 241-247.
15. DE VRIES, T.J., TJON TIEN RIL, G.H.K., VAN DER LAAN, J.W., MULDER, A.H. & SCHOFFELMEER, A.N.M. (1993). Chronic exposure to morphine and naltrexone induces changes in catecholaminergic neurotransmission in rat brain without altering μ-opioid receptor sensitivity. Life Sci., 52, 1685-1693.
16. DUMAN, R.S., TALIMAN, J.F. & NESTLER, F.J. (1988). Acute and chronic opiate-regulation of adenylate cyclase in brain: specific effects in locus coeruleus. J. Pharmacol. Exp. Ther., 246, 1033-1039.
17. ERSPAMER, V., MELCHIORRI, P., FALCONIERI-ERSPAMER, G., NEGRI, L., CORSI, R., SEVERINI, C., BARRA, D., SIMMACO, M. & KREIL, G. (1989). Deltorphins; a family of naturally occurring peptides with high affinity and selectivity for δ opioid binding sites. Proc. Natl. Acad. Sci. U.S.A., 86, 5188-5192.
18. 61-64 possessing selective agonist activity at μ-opiate receptors. Eur. J. Pharmacol., 70, 531-540.
19. HUSTON-LYONS, D., BAIN, G.T. & KORNETSKY, C. (1989). Opiate dependence alters central reward of nalbuphine or pentazocine plus tripelennamine. Eur. J. Pharmacol., 169, 153-157.
20. JACQUET, Y.F. & LAJTHA, A. (1976). The periaqueductal gray: site of morphine analgesia and tolerance as shown by 2-way cross-tolerance between systemic and intracerebral injection. Brain Res., 103, 501-513.
21. KAYSER, V., BENOIST, J.M., GAUTRON, M. & GUILBAUD, G. (1984). Effects of ES52, an enkephalinase inhibitor, on response of ventrobasal thalamic neurons in rat. Peptides, 5, 1159-1165.
22. KEAY, K.A., CLEMENT, C.I., OWLER, B., DEPAULIS, A. & BANDLER, R. (1994). Convergence of deep somatic and visceral nociceptive information onto a discrete ventrolateral midbrain periaqueductal gray region. Neuroscience, 61, 727-732.
23. KEMP, M., ROBERTS, P., POOK, P., JANE, D., JONES, A., SUNTER, D., UDVARHELYI, P. & WATKINS, J. (1994). Antagonism of presynaptically mediated depressant responses and cyclic AMP-coupled metabotropic glutamate receptors. Eur. J. Pharmacol. Mol. Pharmacol. Sec., 266, 187-192.
24. KOOB, G.F., WALL, T.L. & BLOOM, F.E. (1989). Nucleus accumbens as a substrate for the aversive stimulus effects of opiate withdrawal. Psychopharmacology, 98, 530-534.
25. LASCHKA, E., TESCHEMACHER, P., MEHRAIN, P. & HERZ, A. (1976). Sites of action of morphine involved in the development of physical dependence in rats, II. Morphine withdrawal precipitated by application of morphine-antagonists into restricted parts of the ventricular system and by microinjection into various brain areas. Psychopharmacologia, 46, 141-147.
26. 1a receptor antagonist. Pharmacol. Biochem. Behav., 38, 555-559.
27. MALDONADO, R., STINUS, L., GOLD, L.H. & KOOB, G.F. (1992). Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J. Pharmacol. Exp. Ther., 261, 669-677.
28. MALIN, D.H., HARTER, L., JENKINS, P.D., MONFORT, R.D., BRUCE, P.D., FARLEY, P.A., FEREBEE, R., THRASHER, K.L. & MARULLO, D.S. (1987). Cerebrospinal fluid from morphine-dependent rats precipitates opiate abstinence syndrome. Life Sci., 41, 377-383.
29. MARTIN, G.R. & HUMPHREY, P.P.A. (1994). Classification review: receptors for 5-hydroxytryptamine: current perspectives on classification and nomenclature. Neuropharmacology, 33, 261-273.
30. MATSUOKA, L. MALDONADO, R., DEFER, N., NOËL, F., HANOUNE, J. & ROQUES, B.P. (1994). Chronic morphine administration causes region-specific increase of brain type VIII adenylyl cyclase mRNA. Eur. J. Pharmacol. Mol. Pharmacol. Sec., 268, 215-221.
31. MOGIL, J.S., MAREK, P., OTOOLE, L.A., HELMS, M.L., SADOWSKI, B., LIEBESKIND, J.C. & BELKNAP, J.K. (1994). Mu opiate receptor binding is up-regulated in mice selectively bred for high stress-induced analgesia. Brain Res., 653, 16-22.
32. 2+-inhibitable adenylyl cyclase in dopaminergically innervated rat brain regions. Mol. Brain. Res., 22, 236-244.
33. MOSBERG, H.I., HURST, R., HRUBY, V.I., GEE, K., YAMAMURA, H.I., GALLIGAN, J.J. & BURKS, T.F. (1983). Bis-penicillamine enkephalins show pronounced delta receptor selectivity. Proc. Natl. Avad. Sci. USA. 80, 5871-5874.
34. NESTLER, E.J., ERDOS, J.J., TERWILLIGER, R., DUMAN, R.S. & TALLMAN, J.F. (1989). Regulation of G proteins by chronic morphine in the rat locus coeruleus. Brain. Res., 476, 230-239.
35. NESTLER, E.J., HOPE, B.T. & WILDNELL, K.L. (1993). Drug addiction: a model for the molecular basis of neural plasticity. Neuron., 11, 995-1006.
36. NESTLER, E.J. & TALLMAN, J.F. (1988). Chronic morphine treatment increases cyclic AMP-dependent protein kinase activity in the rat locus coeruleus. Mol. Pharmacol., 33, 127-132.
37. 2-opioid agonists in rat caudate putamen. J. Neurochem., 65, 125-133.
38. OKAMOTO, N., HORI, S., AKAZAWA, C., HAYASHI, Y., SHIGEMOTO, R., MIZUNO, N. & NAKANISHI, S. (1994). Molecular characterization of a new metabotropic glutamate receptor mGluR7 coupled to inhibitory cyclic AMP signal transduction. J. Biol. Chem., 269, 1231-1236.
39. PARONIS, C.A. & HOLTZMAN, S.G. (1992). Development of tolerance to the analgesic activity of mu agonists after continous infusion of morphine, meperidine or fentanyl in rats. J. Pharmacol. Exp. Ther., 262, 1-9.
40. PELLEGRINO, L.J., PELLEGRINO, A.S. & CUSHMAN, A.J. (1979). A Stereotaxic Atlas of the Rut Brain. New York: Plenum Press.
41. PETERSON, G.L. (1977). A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal. Biochem., 83, 346-356.
42. 5-enkephalinamide into the ventral tegmental area. Behav. Brain Res., 5, 225-229.
43. PUTTFARCKEN, P.S. & COX, B.M. (1989). Morphine-induced densensitization and down-regulation at mu-receptors in 7315c pituitary tumor cells. Life Sci., 45, 1937-1942.
44. PUTTFARCKEN, P.S., WERLING, L.L. & COX, B.M. (1988). Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: a useful model for the study of tolerance at μ opioid receptors. Mol. Pharmacol., 33, 520-527.
45. RASMUSSEN, K., BEITNER-JOHNSON, D.B., KRYSTAL, J.H., AOHAJANIAN, G.K. NESTLER, B.J. (1990). Opiate withdrawal and the rat locus coeruleus: behavioural, electrophysiological, and biochemical correlates. J. Neurosci., 10, 2308-2317.
46. ROBERTS, V.J. & DONG, W.K. (1994). The effect of thalamic nucleus submedius lesions on nociceptive responding in rats. Pain, 57, 341-349.
47. SCHAEFER, G.J. & MICHAEL, R.P. (1986). Changes in response rates and reinforcement thresholds for intracranial self-stimulation during morphine withdrawal. Pharmacol. Biochem. Behav, 25, 1263-1269.
48. SHARMA, S.K., KLEE, W.A. & NIRENBERG, M. (1975). Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. Proc. Natl. Acad. Sci. USA, 72, 3092-3096.
49. SHARPE, L.G., GARNETT, J.E. & CICERO, T.J. (1974). Analgesia and hyperreactivity produced by intracranial microinjections of morphine into the periaqueductal gray matter of the rat. Behav. Biol., 11, 303-313.
50. STINUS, L., LE MOAL, M. & KOOB, G.F. (1990). Nucleus accumbens and amygdala arc possible substrates for the aversive stimulus effects of opiate withdrawal. Neuroscience, 37, 767-773.
51. TANABE, Y., NOMURA, A., MASU, M., SHIGEMOTO, R., MIZUNO, N. & SHIGETADA, N. (1993). Signal transduction, pharmacological properties, and expression patterns of two rat metabotropic glutamate receptors, mGluR3 and mGluR4. J. Neurosci., 13, 1372-1378.
52. TERWILUGER, R.Z., BEITNER-JOHNSON, D., SEVARINO, K.A., CRAIN, S.M. & NESTLER, E.J. (1991). A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res., 548, 100-110.
53. UNTERWALD, E.M., COX, B.M., KREEK, M.J., COTE, T.E. & IZENWASSER, S. (1993). Chronic repeated cocaine administration alters basal and opioid-regulated adenylyl cyclase activity, Synapse, 15, 33-38.
54. URBAN, M.O. & SMITH, D.J. (1994). Nuclei within the rostral ventromedial medulla mediating morphine antinociception from the periaqueductal gray. Brain Res., 652, 9-16.